Mesoblast Ownership | Who Owns Mesoblast?
Mesoblast Ownership Summary
Mesoblast is owned by 0.27% institutional investors, 0.07% insiders, and 99.66% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 0.06% of MESO shares. iShares Biotechnology ETF is the top mutual fund, with 0.45% of its assets in Mesoblast shares.
MESO Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Mesoblast | 0.27% | 0.07% | 99.66% |
Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Blackrock funding, inc. /de | 727.25K | 0.06% | $14.40M |
Oaktree capital management lp | 179.59K | 0.02% | $3.56M |
Ubs group | 168.25K | 0.01% | $3.33M |
Susquehanna group, llp | 153.98K | 0.01% | $3.05M |
Summit x | 145.66K | 0.01% | $2.88M |
Jane street group | 102.17K | 0.01% | $2.02M |
Citigroup | 100.00K | 0.01% | $1.98M |
Prosperity wealth management | 93.25K | 0.01% | $1.85M |
Penbrook management | 91.08K | 0.01% | $1.80M |
Rockbridge investment management, lcc | 49.15K | 0.00% | $973.17K |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Oaktree fund advisors | 47.91K | 1.59% | $948.60K |
Penbrook management | 91.08K | 1.23% | $1.80M |
Prosperity wealth management | 93.25K | 0.76% | $1.85M |
Summit x | 145.66K | 0.64% | $2.88M |
Lazari capital management | 45.47K | 0.36% | $900.25K |
Fi3 financial advisors | 36.63K | 0.27% | $725.17K |
Rockbridge investment management, lcc | 49.15K | 0.12% | $973.17K |
Entrypoint capital | 12.32K | 0.10% | $244.03K |
Sio capital management | 11.60K | 0.06% | $229.68K |
Oaktree capital management lp | 179.59K | 0.06% | $3.56M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Blackrock funding, inc. /de | 727.25K | 0.00% | 645.77K |
Oaktree capital management lp | 179.59K | 0.06% | 179.59K |
Ubs group | 168.25K | 0.00% | 168.25K |
Citigroup | 100.00K | 0.00% | 100.00K |
Oaktree fund advisors | 47.91K | 1.59% | 47.91K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Group one trading | - | - | -253.38K |
Xy capital | - | - | -29.85K |
Two sigma investments, lp | - | - | -20.35K |
Marshall wace, llp | - | - | -17.72K |
Penbrook management | 91.08K | 1.23% | -16.20K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Oaktree capital management lp | 179.59K | 0.06% | 179.59K | $3.56M |
Ubs group | 168.25K | 0.00% | 168.25K | $3.33M |
Citigroup | 100.00K | 0.00% | 100.00K | $1.98M |
Oaktree fund advisors | 47.91K | 1.59% | 47.91K | $948.60K |
Thoroughbred financial services | 17.14K | 0.02% | 17.14K | $339.00K |
Sold Out
Holder | Change |
---|---|
Perkins coie trust | -11.50K |
Millennium management | -14.66K |
Marshall wace, llp | -17.72K |
Two sigma investments, lp | -20.35K |
Xy capital | -29.85K |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2024 | 63 | 34.04% | 2,979,315 | 92.78% | - | 10.82% | 42 | 90.91% | 8 | -33.33% |
Sep 30, 2024 | 45 | - | 1,532,837 | 3.28% | 1 | 68.66% | 21 | -32.26% | 12 | 300.00% |
Jun 30, 2024 | 45 | 40.63% | 1,484,211 | 36.87% | 1 | 124.54% | 31 | 82.35% | 3 | -72.73% |
Mar 31, 2024 | 32 | - | 1,084,385 | -7.60% | 1 | 310.73% | 17 | 30.77% | 11 | 37.50% |
Dec 31, 2023 | 32 | -17.95% | 1,173,622 | -11.54% | - | 96.41% | 13 | -7.14% | 8 | -33.33% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
iShares Biotechnology ETF | 565.89K | 0.45% | -6.30K |
Fidelity Nasdaq Composite Index | 18.25K | 0.01% | - |
iShares Nasdaq US Biotech ETF USD Acc | 16.55K | 0.01% | -174.00 |
VT Downing Global Investors F Inc | 12.50K | 0.01% | 12.50K |
ActivePassive International Equity ETF | 8.47K | 0.01% | - |
China Universal NASDAQ Bio-Tch ETF(QDII) | 6.78K | 0.01% | 6.78K |
ProShares Ultra Nasdaq Biotechnology | 1.53K | 0.00% | - |
Invesco Nasdaq Biotechnology ETF | 1.42K | 0.00% | - |
Quantified Global Fund Investor | 1.41K | 0.00% | -4.99K |
TIGER NASDAQ BIO | 1.04K | 0.00% | -20.00 |
MESO Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools